News & Analysis on Clinical Trial Services & Contract Research And Development
The US authorities are turning up the heat on Icelandic generic drugmaker Actavis over manufacturing problems at the New Jersey plant which makes its recalled Digitek brand of the cardiac drug digoxin.
Philips’ new intelligent pill (iPill) technology, which combines a sophisticate sensor array with a precise delivery mechanism, was one of the most talked about innovation presented at this year’s AAPS meeting in Atlanta.
Manufacturers of ingredients used as excipients in pharmaceuticals have faced some regulatory problems with a series substances known as 'atypical actives'.
Contract research group Recipharm has leased AstraZeneca Biotech Laboratory (ABL) in Sodertalje, Sweden, bolting on recombinant protein and monoclonal antibody development capabilities to its offering.
DSM Deretil, the chemical side-chain manufacturing operation of DSM's anti-infectives unit, is to go it alone through a management buyout.
German chemical giant BASF chose this year’s AAPS meeting in Atlanta, US to showcase its growing library of USP excipient verification certificates, making good on its commitment to apply the highest manufacturing standards to this area of its business.
Outsourcing-Pharma.com presents its periodic round-up of executive appointments in the contract services sector.
CiVentiChem president Bhaskar Venepalli says that the CiVentiAnalytical unit, the firm’s new state of the art GLP/cGMP accredited laboratory in Cary, North Carolina, will help customers find novel method development solutions for API production.
Eli Lilly has continued its march down the outsourcing route and signed a wide-ranging deal with Ireland’s Icon plc in the area of data management.